Global Lacosamide Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Lacosamide (INN, formerly known as erlosamide, harkeroside, SPM 927, or ADD 234037), is a medication for the adjunctive treatment of partial-onset seizures and diabetic neuropathic pain. It is marketed under the trade name Vimpat.
LPI (LP Information)' newest research report, the “Lacosamide Industry Forecast” looks at past sales and reviews total world Lacosamide sales in 2022, providing a comprehensive analysis by region and market sector of projected Lacosamide sales for 2023 through 2029. With Lacosamide sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Lacosamide industry.
This Insight Report provides a comprehensive analysis of the global Lacosamide landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Lacosamide portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Lacosamide market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Lacosamide and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Lacosamide.
The global Lacosamide market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Lacosamide is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Lacosamide is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Lacosamide is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Lacosamide players cover UCB, Teva, Amneal Pharmaceuticals, MSN Laboratories, Alembic Pharma, Glenmark, Aurobindo Pharma, Accord Healthcare and Mylan, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Lacosamide market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Lacosamide (INN, formerly known as erlosamide, harkeroside, SPM 927, or ADD 234037), is a medication for the adjunctive treatment of partial-onset seizures and diabetic neuropathic pain. It is marketed under the trade name Vimpat.
LPI (LP Information)' newest research report, the “Lacosamide Industry Forecast” looks at past sales and reviews total world Lacosamide sales in 2022, providing a comprehensive analysis by region and market sector of projected Lacosamide sales for 2023 through 2029. With Lacosamide sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Lacosamide industry.
This Insight Report provides a comprehensive analysis of the global Lacosamide landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Lacosamide portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Lacosamide market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Lacosamide and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Lacosamide.
The global Lacosamide market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Lacosamide is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Lacosamide is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Lacosamide is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Lacosamide players cover UCB, Teva, Amneal Pharmaceuticals, MSN Laboratories, Alembic Pharma, Glenmark, Aurobindo Pharma, Accord Healthcare and Mylan, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Lacosamide market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- Oral tablets
- Oral solution
- Intravenous
- Adults
- Pediatric patients
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- UCB
- Teva
- Amneal Pharmaceuticals
- MSN Laboratories
- Alembic Pharma
- Glenmark
- Aurobindo Pharma
- Accord Healthcare
- Mylan
- Sun Pharma
- Apotex
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Lacosamide Market Size 2018-2029
2.1.2 Lacosamide Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Lacosamide Segment by Type
2.2.1 Oral tablets
2.2.2 Oral solution
2.2.3 Intravenous
2.3 Lacosamide Market Size by Type
2.3.1 Lacosamide Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Lacosamide Market Size Market Share by Type (2018-2023)
2.4 Lacosamide Segment by Application
2.4.1 Adults
2.4.2 Pediatric patients
2.5 Lacosamide Market Size by Application
2.5.1 Lacosamide Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Lacosamide Market Size Market Share by Application (2018-2023)
3 LACOSAMIDE MARKET SIZE BY PLAYER
3.1 Lacosamide Market Size Market Share by Players
3.1.1 Global Lacosamide Revenue by Players (2018-2023)
3.1.2 Global Lacosamide Revenue Market Share by Players (2018-2023)
3.2 Global Lacosamide Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 LACOSAMIDE BY REGIONS
4.1 Lacosamide Market Size by Regions (2018-2023)
4.2 Americas Lacosamide Market Size Growth (2018-2023)
4.3 APAC Lacosamide Market Size Growth (2018-2023)
4.4 Europe Lacosamide Market Size Growth (2018-2023)
4.5 Middle East & Africa Lacosamide Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Lacosamide Market Size by Country (2018-2023)
5.2 Americas Lacosamide Market Size by Type (2018-2023)
5.3 Americas Lacosamide Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Lacosamide Market Size by Region (2018-2023)
6.2 APAC Lacosamide Market Size by Type (2018-2023)
6.3 APAC Lacosamide Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Lacosamide by Country (2018-2023)
7.2 Europe Lacosamide Market Size by Type (2018-2023)
7.3 Europe Lacosamide Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Lacosamide by Region (2018-2023)
8.2 Middle East & Africa Lacosamide Market Size by Type (2018-2023)
8.3 Middle East & Africa Lacosamide Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL LACOSAMIDE MARKET FORECAST
10.1 Global Lacosamide Forecast by Regions (2024-2029)
10.1.1 Global Lacosamide Forecast by Regions (2024-2029)
10.1.2 Americas Lacosamide Forecast
10.1.3 APAC Lacosamide Forecast
10.1.4 Europe Lacosamide Forecast
10.1.5 Middle East & Africa Lacosamide Forecast
10.2 Americas Lacosamide Forecast by Country (2024-2029)
10.2.1 United States Lacosamide Market Forecast
10.2.2 Canada Lacosamide Market Forecast
10.2.3 Mexico Lacosamide Market Forecast
10.2.4 Brazil Lacosamide Market Forecast
10.3 APAC Lacosamide Forecast by Region (2024-2029)
10.3.1 China Lacosamide Market Forecast
10.3.2 Japan Lacosamide Market Forecast
10.3.3 Korea Lacosamide Market Forecast
10.3.4 Southeast Asia Lacosamide Market Forecast
10.3.5 India Lacosamide Market Forecast
10.3.6 Australia Lacosamide Market Forecast
10.4 Europe Lacosamide Forecast by Country (2024-2029)
10.4.1 Germany Lacosamide Market Forecast
10.4.2 France Lacosamide Market Forecast
10.4.3 UK Lacosamide Market Forecast
10.4.4 Italy Lacosamide Market Forecast
10.4.5 Russia Lacosamide Market Forecast
10.5 Middle East & Africa Lacosamide Forecast by Region (2024-2029)
10.5.1 Egypt Lacosamide Market Forecast
10.5.2 South Africa Lacosamide Market Forecast
10.5.3 Israel Lacosamide Market Forecast
10.5.4 Turkey Lacosamide Market Forecast
10.5.5 GCC Countries Lacosamide Market Forecast
10.6 Global Lacosamide Forecast by Type (2024-2029)
10.7 Global Lacosamide Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 UCB
11.1.1 UCB Company Information
11.1.2 UCB Lacosamide Product Offered
11.1.3 UCB Lacosamide Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 UCB Main Business Overview
11.1.5 UCB Latest Developments
11.2 Teva
11.2.1 Teva Company Information
11.2.2 Teva Lacosamide Product Offered
11.2.3 Teva Lacosamide Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Teva Main Business Overview
11.2.5 Teva Latest Developments
11.3 Amneal Pharmaceuticals
11.3.1 Amneal Pharmaceuticals Company Information
11.3.2 Amneal Pharmaceuticals Lacosamide Product Offered
11.3.3 Amneal Pharmaceuticals Lacosamide Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Amneal Pharmaceuticals Main Business Overview
11.3.5 Amneal Pharmaceuticals Latest Developments
11.4 MSN Laboratories
11.4.1 MSN Laboratories Company Information
11.4.2 MSN Laboratories Lacosamide Product Offered
11.4.3 MSN Laboratories Lacosamide Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 MSN Laboratories Main Business Overview
11.4.5 MSN Laboratories Latest Developments
11.5 Alembic Pharma
11.5.1 Alembic Pharma Company Information
11.5.2 Alembic Pharma Lacosamide Product Offered
11.5.3 Alembic Pharma Lacosamide Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Alembic Pharma Main Business Overview
11.5.5 Alembic Pharma Latest Developments
11.6 Glenmark
11.6.1 Glenmark Company Information
11.6.2 Glenmark Lacosamide Product Offered
11.6.3 Glenmark Lacosamide Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Glenmark Main Business Overview
11.6.5 Glenmark Latest Developments
11.7 Aurobindo Pharma
11.7.1 Aurobindo Pharma Company Information
11.7.2 Aurobindo Pharma Lacosamide Product Offered
11.7.3 Aurobindo Pharma Lacosamide Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Aurobindo Pharma Main Business Overview
11.7.5 Aurobindo Pharma Latest Developments
11.8 Accord Healthcare
11.8.1 Accord Healthcare Company Information
11.8.2 Accord Healthcare Lacosamide Product Offered
11.8.3 Accord Healthcare Lacosamide Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Accord Healthcare Main Business Overview
11.8.5 Accord Healthcare Latest Developments
11.9 Mylan
11.9.1 Mylan Company Information
11.9.2 Mylan Lacosamide Product Offered
11.9.3 Mylan Lacosamide Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Mylan Main Business Overview
11.9.5 Mylan Latest Developments
11.10 Sun Pharma
11.10.1 Sun Pharma Company Information
11.10.2 Sun Pharma Lacosamide Product Offered
11.10.3 Sun Pharma Lacosamide Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Sun Pharma Main Business Overview
11.10.5 Sun Pharma Latest Developments
11.11 Apotex
11.11.1 Apotex Company Information
11.11.2 Apotex Lacosamide Product Offered
11.11.3 Apotex Lacosamide Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Apotex Main Business Overview
11.11.5 Apotex Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Lacosamide Market Size 2018-2029
2.1.2 Lacosamide Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Lacosamide Segment by Type
2.2.1 Oral tablets
2.2.2 Oral solution
2.2.3 Intravenous
2.3 Lacosamide Market Size by Type
2.3.1 Lacosamide Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Lacosamide Market Size Market Share by Type (2018-2023)
2.4 Lacosamide Segment by Application
2.4.1 Adults
2.4.2 Pediatric patients
2.5 Lacosamide Market Size by Application
2.5.1 Lacosamide Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Lacosamide Market Size Market Share by Application (2018-2023)
3 LACOSAMIDE MARKET SIZE BY PLAYER
3.1 Lacosamide Market Size Market Share by Players
3.1.1 Global Lacosamide Revenue by Players (2018-2023)
3.1.2 Global Lacosamide Revenue Market Share by Players (2018-2023)
3.2 Global Lacosamide Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 LACOSAMIDE BY REGIONS
4.1 Lacosamide Market Size by Regions (2018-2023)
4.2 Americas Lacosamide Market Size Growth (2018-2023)
4.3 APAC Lacosamide Market Size Growth (2018-2023)
4.4 Europe Lacosamide Market Size Growth (2018-2023)
4.5 Middle East & Africa Lacosamide Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Lacosamide Market Size by Country (2018-2023)
5.2 Americas Lacosamide Market Size by Type (2018-2023)
5.3 Americas Lacosamide Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Lacosamide Market Size by Region (2018-2023)
6.2 APAC Lacosamide Market Size by Type (2018-2023)
6.3 APAC Lacosamide Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Lacosamide by Country (2018-2023)
7.2 Europe Lacosamide Market Size by Type (2018-2023)
7.3 Europe Lacosamide Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Lacosamide by Region (2018-2023)
8.2 Middle East & Africa Lacosamide Market Size by Type (2018-2023)
8.3 Middle East & Africa Lacosamide Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL LACOSAMIDE MARKET FORECAST
10.1 Global Lacosamide Forecast by Regions (2024-2029)
10.1.1 Global Lacosamide Forecast by Regions (2024-2029)
10.1.2 Americas Lacosamide Forecast
10.1.3 APAC Lacosamide Forecast
10.1.4 Europe Lacosamide Forecast
10.1.5 Middle East & Africa Lacosamide Forecast
10.2 Americas Lacosamide Forecast by Country (2024-2029)
10.2.1 United States Lacosamide Market Forecast
10.2.2 Canada Lacosamide Market Forecast
10.2.3 Mexico Lacosamide Market Forecast
10.2.4 Brazil Lacosamide Market Forecast
10.3 APAC Lacosamide Forecast by Region (2024-2029)
10.3.1 China Lacosamide Market Forecast
10.3.2 Japan Lacosamide Market Forecast
10.3.3 Korea Lacosamide Market Forecast
10.3.4 Southeast Asia Lacosamide Market Forecast
10.3.5 India Lacosamide Market Forecast
10.3.6 Australia Lacosamide Market Forecast
10.4 Europe Lacosamide Forecast by Country (2024-2029)
10.4.1 Germany Lacosamide Market Forecast
10.4.2 France Lacosamide Market Forecast
10.4.3 UK Lacosamide Market Forecast
10.4.4 Italy Lacosamide Market Forecast
10.4.5 Russia Lacosamide Market Forecast
10.5 Middle East & Africa Lacosamide Forecast by Region (2024-2029)
10.5.1 Egypt Lacosamide Market Forecast
10.5.2 South Africa Lacosamide Market Forecast
10.5.3 Israel Lacosamide Market Forecast
10.5.4 Turkey Lacosamide Market Forecast
10.5.5 GCC Countries Lacosamide Market Forecast
10.6 Global Lacosamide Forecast by Type (2024-2029)
10.7 Global Lacosamide Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 UCB
11.1.1 UCB Company Information
11.1.2 UCB Lacosamide Product Offered
11.1.3 UCB Lacosamide Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 UCB Main Business Overview
11.1.5 UCB Latest Developments
11.2 Teva
11.2.1 Teva Company Information
11.2.2 Teva Lacosamide Product Offered
11.2.3 Teva Lacosamide Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Teva Main Business Overview
11.2.5 Teva Latest Developments
11.3 Amneal Pharmaceuticals
11.3.1 Amneal Pharmaceuticals Company Information
11.3.2 Amneal Pharmaceuticals Lacosamide Product Offered
11.3.3 Amneal Pharmaceuticals Lacosamide Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Amneal Pharmaceuticals Main Business Overview
11.3.5 Amneal Pharmaceuticals Latest Developments
11.4 MSN Laboratories
11.4.1 MSN Laboratories Company Information
11.4.2 MSN Laboratories Lacosamide Product Offered
11.4.3 MSN Laboratories Lacosamide Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 MSN Laboratories Main Business Overview
11.4.5 MSN Laboratories Latest Developments
11.5 Alembic Pharma
11.5.1 Alembic Pharma Company Information
11.5.2 Alembic Pharma Lacosamide Product Offered
11.5.3 Alembic Pharma Lacosamide Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Alembic Pharma Main Business Overview
11.5.5 Alembic Pharma Latest Developments
11.6 Glenmark
11.6.1 Glenmark Company Information
11.6.2 Glenmark Lacosamide Product Offered
11.6.3 Glenmark Lacosamide Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Glenmark Main Business Overview
11.6.5 Glenmark Latest Developments
11.7 Aurobindo Pharma
11.7.1 Aurobindo Pharma Company Information
11.7.2 Aurobindo Pharma Lacosamide Product Offered
11.7.3 Aurobindo Pharma Lacosamide Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Aurobindo Pharma Main Business Overview
11.7.5 Aurobindo Pharma Latest Developments
11.8 Accord Healthcare
11.8.1 Accord Healthcare Company Information
11.8.2 Accord Healthcare Lacosamide Product Offered
11.8.3 Accord Healthcare Lacosamide Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Accord Healthcare Main Business Overview
11.8.5 Accord Healthcare Latest Developments
11.9 Mylan
11.9.1 Mylan Company Information
11.9.2 Mylan Lacosamide Product Offered
11.9.3 Mylan Lacosamide Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Mylan Main Business Overview
11.9.5 Mylan Latest Developments
11.10 Sun Pharma
11.10.1 Sun Pharma Company Information
11.10.2 Sun Pharma Lacosamide Product Offered
11.10.3 Sun Pharma Lacosamide Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Sun Pharma Main Business Overview
11.10.5 Sun Pharma Latest Developments
11.11 Apotex
11.11.1 Apotex Company Information
11.11.2 Apotex Lacosamide Product Offered
11.11.3 Apotex Lacosamide Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Apotex Main Business Overview
11.11.5 Apotex Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Lacosamide Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Oral tablets
Table 3. Major Players of Oral solution
Table 4. Major Players of Intravenous
Table 5. Lacosamide Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 6. Global Lacosamide Market Size by Type (2018-2023) & ($ Millions)
Table 7. Global Lacosamide Market Size Market Share by Type (2018-2023)
Table 8. Lacosamide Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 9. Global Lacosamide Market Size by Application (2018-2023) & ($ Millions)
Table 10. Global Lacosamide Market Size Market Share by Application (2018-2023)
Table 11. Global Lacosamide Revenue by Players (2018-2023) & ($ Millions)
Table 12. Global Lacosamide Revenue Market Share by Player (2018-2023)
Table 13. Lacosamide Key Players Head office and Products Offered
Table 14. Lacosamide Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Lacosamide Market Size by Regions 2018-2023 & ($ Millions)
Table 18. Global Lacosamide Market Size Market Share by Regions (2018-2023)
Table 19. Global Lacosamide Revenue by Country/Region (2018-2023) & ($ millions)
Table 20. Global Lacosamide Revenue Market Share by Country/Region (2018-2023)
Table 21. Americas Lacosamide Market Size by Country (2018-2023) & ($ Millions)
Table 22. Americas Lacosamide Market Size Market Share by Country (2018-2023)
Table 23. Americas Lacosamide Market Size by Type (2018-2023) & ($ Millions)
Table 24. Americas Lacosamide Market Size Market Share by Type (2018-2023)
Table 25. Americas Lacosamide Market Size by Application (2018-2023) & ($ Millions)
Table 26. Americas Lacosamide Market Size Market Share by Application (2018-2023)
Table 27. APAC Lacosamide Market Size by Region (2018-2023) & ($ Millions)
Table 28. APAC Lacosamide Market Size Market Share by Region (2018-2023)
Table 29. APAC Lacosamide Market Size by Type (2018-2023) & ($ Millions)
Table 30. APAC Lacosamide Market Size Market Share by Type (2018-2023)
Table 31. APAC Lacosamide Market Size by Application (2018-2023) & ($ Millions)
Table 32. APAC Lacosamide Market Size Market Share by Application (2018-2023)
Table 33. Europe Lacosamide Market Size by Country (2018-2023) & ($ Millions)
Table 34. Europe Lacosamide Market Size Market Share by Country (2018-2023)
Table 35. Europe Lacosamide Market Size by Type (2018-2023) & ($ Millions)
Table 36. Europe Lacosamide Market Size Market Share by Type (2018-2023)
Table 37. Europe Lacosamide Market Size by Application (2018-2023) & ($ Millions)
Table 38. Europe Lacosamide Market Size Market Share by Application (2018-2023)
Table 39. Middle East & Africa Lacosamide Market Size by Region (2018-2023) & ($ Millions)
Table 40. Middle East & Africa Lacosamide Market Size Market Share by Region (2018-2023)
Table 41. Middle East & Africa Lacosamide Market Size by Type (2018-2023) & ($ Millions)
Table 42. Middle East & Africa Lacosamide Market Size Market Share by Type (2018-2023)
Table 43. Middle East & Africa Lacosamide Market Size by Application (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Lacosamide Market Size Market Share by Application (2018-2023)
Table 45. Key Market Drivers & Growth Opportunities of Lacosamide
Table 46. Key Market Challenges & Risks of Lacosamide
Table 47. Key Industry Trends of Lacosamide
Table 48. Global Lacosamide Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 49. Global Lacosamide Market Size Market Share Forecast by Regions (2024-2029)
Table 50. Global Lacosamide Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 51. Global Lacosamide Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 52. UCB Details, Company Type, Lacosamide Area Served and Its Competitors
Table 53. UCB Lacosamide Product Offered
Table 54. UCB Lacosamide Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 55. UCB Main Business
Table 56. UCB Latest Developments
Table 57. Teva Details, Company Type, Lacosamide Area Served and Its Competitors
Table 58. Teva Lacosamide Product Offered
Table 59. Teva Main Business
Table 60. Teva Lacosamide Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 61. Teva Latest Developments
Table 62. Amneal Pharmaceuticals Details, Company Type, Lacosamide Area Served and Its Competitors
Table 63. Amneal Pharmaceuticals Lacosamide Product Offered
Table 64. Amneal Pharmaceuticals Main Business
Table 65. Amneal Pharmaceuticals Lacosamide Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 66. Amneal Pharmaceuticals Latest Developments
Table 67. MSN Laboratories Details, Company Type, Lacosamide Area Served and Its Competitors
Table 68. MSN Laboratories Lacosamide Product Offered
Table 69. MSN Laboratories Main Business
Table 70. MSN Laboratories Lacosamide Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 71. MSN Laboratories Latest Developments
Table 72. Alembic Pharma Details, Company Type, Lacosamide Area Served and Its Competitors
Table 73. Alembic Pharma Lacosamide Product Offered
Table 74. Alembic Pharma Main Business
Table 75. Alembic Pharma Lacosamide Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 76. Alembic Pharma Latest Developments
Table 77. Glenmark Details, Company Type, Lacosamide Area Served and Its Competitors
Table 78. Glenmark Lacosamide Product Offered
Table 79. Glenmark Main Business
Table 80. Glenmark Lacosamide Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 81. Glenmark Latest Developments
Table 82. Aurobindo Pharma Details, Company Type, Lacosamide Area Served and Its Competitors
Table 83. Aurobindo Pharma Lacosamide Product Offered
Table 84. Aurobindo Pharma Main Business
Table 85. Aurobindo Pharma Lacosamide Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 86. Aurobindo Pharma Latest Developments
Table 87. Accord Healthcare Details, Company Type, Lacosamide Area Served and Its Competitors
Table 88. Accord Healthcare Lacosamide Product Offered
Table 89. Accord Healthcare Main Business
Table 90. Accord Healthcare Lacosamide Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 91. Accord Healthcare Latest Developments
Table 92. Mylan Details, Company Type, Lacosamide Area Served and Its Competitors
Table 93. Mylan Lacosamide Product Offered
Table 94. Mylan Main Business
Table 95. Mylan Lacosamide Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 96. Mylan Latest Developments
Table 97. Sun Pharma Details, Company Type, Lacosamide Area Served and Its Competitors
Table 98. Sun Pharma Lacosamide Product Offered
Table 99. Sun Pharma Main Business
Table 100. Sun Pharma Lacosamide Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 101. Sun Pharma Latest Developments
Table 102. Apotex Details, Company Type, Lacosamide Area Served and Its Competitors
Table 103. Apotex Lacosamide Product Offered
Table 104. Apotex Lacosamide Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 105. Apotex Main Business
Table 106. Apotex Latest Developments
Table 1. Lacosamide Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Oral tablets
Table 3. Major Players of Oral solution
Table 4. Major Players of Intravenous
Table 5. Lacosamide Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 6. Global Lacosamide Market Size by Type (2018-2023) & ($ Millions)
Table 7. Global Lacosamide Market Size Market Share by Type (2018-2023)
Table 8. Lacosamide Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 9. Global Lacosamide Market Size by Application (2018-2023) & ($ Millions)
Table 10. Global Lacosamide Market Size Market Share by Application (2018-2023)
Table 11. Global Lacosamide Revenue by Players (2018-2023) & ($ Millions)
Table 12. Global Lacosamide Revenue Market Share by Player (2018-2023)
Table 13. Lacosamide Key Players Head office and Products Offered
Table 14. Lacosamide Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Lacosamide Market Size by Regions 2018-2023 & ($ Millions)
Table 18. Global Lacosamide Market Size Market Share by Regions (2018-2023)
Table 19. Global Lacosamide Revenue by Country/Region (2018-2023) & ($ millions)
Table 20. Global Lacosamide Revenue Market Share by Country/Region (2018-2023)
Table 21. Americas Lacosamide Market Size by Country (2018-2023) & ($ Millions)
Table 22. Americas Lacosamide Market Size Market Share by Country (2018-2023)
Table 23. Americas Lacosamide Market Size by Type (2018-2023) & ($ Millions)
Table 24. Americas Lacosamide Market Size Market Share by Type (2018-2023)
Table 25. Americas Lacosamide Market Size by Application (2018-2023) & ($ Millions)
Table 26. Americas Lacosamide Market Size Market Share by Application (2018-2023)
Table 27. APAC Lacosamide Market Size by Region (2018-2023) & ($ Millions)
Table 28. APAC Lacosamide Market Size Market Share by Region (2018-2023)
Table 29. APAC Lacosamide Market Size by Type (2018-2023) & ($ Millions)
Table 30. APAC Lacosamide Market Size Market Share by Type (2018-2023)
Table 31. APAC Lacosamide Market Size by Application (2018-2023) & ($ Millions)
Table 32. APAC Lacosamide Market Size Market Share by Application (2018-2023)
Table 33. Europe Lacosamide Market Size by Country (2018-2023) & ($ Millions)
Table 34. Europe Lacosamide Market Size Market Share by Country (2018-2023)
Table 35. Europe Lacosamide Market Size by Type (2018-2023) & ($ Millions)
Table 36. Europe Lacosamide Market Size Market Share by Type (2018-2023)
Table 37. Europe Lacosamide Market Size by Application (2018-2023) & ($ Millions)
Table 38. Europe Lacosamide Market Size Market Share by Application (2018-2023)
Table 39. Middle East & Africa Lacosamide Market Size by Region (2018-2023) & ($ Millions)
Table 40. Middle East & Africa Lacosamide Market Size Market Share by Region (2018-2023)
Table 41. Middle East & Africa Lacosamide Market Size by Type (2018-2023) & ($ Millions)
Table 42. Middle East & Africa Lacosamide Market Size Market Share by Type (2018-2023)
Table 43. Middle East & Africa Lacosamide Market Size by Application (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Lacosamide Market Size Market Share by Application (2018-2023)
Table 45. Key Market Drivers & Growth Opportunities of Lacosamide
Table 46. Key Market Challenges & Risks of Lacosamide
Table 47. Key Industry Trends of Lacosamide
Table 48. Global Lacosamide Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 49. Global Lacosamide Market Size Market Share Forecast by Regions (2024-2029)
Table 50. Global Lacosamide Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 51. Global Lacosamide Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 52. UCB Details, Company Type, Lacosamide Area Served and Its Competitors
Table 53. UCB Lacosamide Product Offered
Table 54. UCB Lacosamide Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 55. UCB Main Business
Table 56. UCB Latest Developments
Table 57. Teva Details, Company Type, Lacosamide Area Served and Its Competitors
Table 58. Teva Lacosamide Product Offered
Table 59. Teva Main Business
Table 60. Teva Lacosamide Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 61. Teva Latest Developments
Table 62. Amneal Pharmaceuticals Details, Company Type, Lacosamide Area Served and Its Competitors
Table 63. Amneal Pharmaceuticals Lacosamide Product Offered
Table 64. Amneal Pharmaceuticals Main Business
Table 65. Amneal Pharmaceuticals Lacosamide Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 66. Amneal Pharmaceuticals Latest Developments
Table 67. MSN Laboratories Details, Company Type, Lacosamide Area Served and Its Competitors
Table 68. MSN Laboratories Lacosamide Product Offered
Table 69. MSN Laboratories Main Business
Table 70. MSN Laboratories Lacosamide Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 71. MSN Laboratories Latest Developments
Table 72. Alembic Pharma Details, Company Type, Lacosamide Area Served and Its Competitors
Table 73. Alembic Pharma Lacosamide Product Offered
Table 74. Alembic Pharma Main Business
Table 75. Alembic Pharma Lacosamide Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 76. Alembic Pharma Latest Developments
Table 77. Glenmark Details, Company Type, Lacosamide Area Served and Its Competitors
Table 78. Glenmark Lacosamide Product Offered
Table 79. Glenmark Main Business
Table 80. Glenmark Lacosamide Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 81. Glenmark Latest Developments
Table 82. Aurobindo Pharma Details, Company Type, Lacosamide Area Served and Its Competitors
Table 83. Aurobindo Pharma Lacosamide Product Offered
Table 84. Aurobindo Pharma Main Business
Table 85. Aurobindo Pharma Lacosamide Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 86. Aurobindo Pharma Latest Developments
Table 87. Accord Healthcare Details, Company Type, Lacosamide Area Served and Its Competitors
Table 88. Accord Healthcare Lacosamide Product Offered
Table 89. Accord Healthcare Main Business
Table 90. Accord Healthcare Lacosamide Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 91. Accord Healthcare Latest Developments
Table 92. Mylan Details, Company Type, Lacosamide Area Served and Its Competitors
Table 93. Mylan Lacosamide Product Offered
Table 94. Mylan Main Business
Table 95. Mylan Lacosamide Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 96. Mylan Latest Developments
Table 97. Sun Pharma Details, Company Type, Lacosamide Area Served and Its Competitors
Table 98. Sun Pharma Lacosamide Product Offered
Table 99. Sun Pharma Main Business
Table 100. Sun Pharma Lacosamide Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 101. Sun Pharma Latest Developments
Table 102. Apotex Details, Company Type, Lacosamide Area Served and Its Competitors
Table 103. Apotex Lacosamide Product Offered
Table 104. Apotex Lacosamide Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 105. Apotex Main Business
Table 106. Apotex Latest Developments
LIST OF FIGURES
Figure 1. Lacosamide Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Lacosamide Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Lacosamide Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Lacosamide Sales Market Share by Country/Region (2022)
Figure 8. Lacosamide Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Lacosamide Market Size Market Share by Type in 2022
Figure 10. Lacosamide in Adults
Figure 11. Global Lacosamide Market: Adults (2018-2023) & ($ Millions)
Figure 12. Lacosamide in Pediatric patients
Figure 13. Global Lacosamide Market: Pediatric patients (2018-2023) & ($ Millions)
Figure 14. Global Lacosamide Market Size Market Share by Application in 2022
Figure 15. Global Lacosamide Revenue Market Share by Player in 2022
Figure 16. Global Lacosamide Market Size Market Share by Regions (2018-2023)
Figure 17. Americas Lacosamide Market Size 2018-2023 ($ Millions)
Figure 18. APAC Lacosamide Market Size 2018-2023 ($ Millions)
Figure 19. Europe Lacosamide Market Size 2018-2023 ($ Millions)
Figure 20. Middle East & Africa Lacosamide Market Size 2018-2023 ($ Millions)
Figure 21. Americas Lacosamide Value Market Share by Country in 2022
Figure 22. United States Lacosamide Market Size Growth 2018-2023 ($ Millions)
Figure 23. Canada Lacosamide Market Size Growth 2018-2023 ($ Millions)
Figure 24. Mexico Lacosamide Market Size Growth 2018-2023 ($ Millions)
Figure 25. Brazil Lacosamide Market Size Growth 2018-2023 ($ Millions)
Figure 26. APAC Lacosamide Market Size Market Share by Region in 2022
Figure 27. APAC Lacosamide Market Size Market Share by Type in 2022
Figure 28. APAC Lacosamide Market Size Market Share by Application in 2022
Figure 29. China Lacosamide Market Size Growth 2018-2023 ($ Millions)
Figure 30. Japan Lacosamide Market Size Growth 2018-2023 ($ Millions)
Figure 31. Korea Lacosamide Market Size Growth 2018-2023 ($ Millions)
Figure 32. Southeast Asia Lacosamide Market Size Growth 2018-2023 ($ Millions)
Figure 33. India Lacosamide Market Size Growth 2018-2023 ($ Millions)
Figure 34. Australia Lacosamide Market Size Growth 2018-2023 ($ Millions)
Figure 35. Europe Lacosamide Market Size Market Share by Country in 2022
Figure 36. Europe Lacosamide Market Size Market Share by Type (2018-2023)
Figure 37. Europe Lacosamide Market Size Market Share by Application (2018-2023)
Figure 38. Germany Lacosamide Market Size Growth 2018-2023 ($ Millions)
Figure 39. France Lacosamide Market Size Growth 2018-2023 ($ Millions)
Figure 40. UK Lacosamide Market Size Growth 2018-2023 ($ Millions)
Figure 41. Italy Lacosamide Market Size Growth 2018-2023 ($ Millions)
Figure 42. Russia Lacosamide Market Size Growth 2018-2023 ($ Millions)
Figure 43. Middle East & Africa Lacosamide Market Size Market Share by Region (2018-2023)
Figure 44. Middle East & Africa Lacosamide Market Size Market Share by Type (2018-2023)
Figure 45. Middle East & Africa Lacosamide Market Size Market Share by Application (2018-2023)
Figure 46. Egypt Lacosamide Market Size Growth 2018-2023 ($ Millions)
Figure 47. South Africa Lacosamide Market Size Growth 2018-2023 ($ Millions)
Figure 48. Israel Lacosamide Market Size Growth 2018-2023 ($ Millions)
Figure 49. Turkey Lacosamide Market Size Growth 2018-2023 ($ Millions)
Figure 50. GCC Country Lacosamide Market Size Growth 2018-2023 ($ Millions)
Figure 51. Americas Lacosamide Market Size 2024-2029 ($ Millions)
Figure 52. APAC Lacosamide Market Size 2024-2029 ($ Millions)
Figure 53. Europe Lacosamide Market Size 2024-2029 ($ Millions)
Figure 54. Middle East & Africa Lacosamide Market Size 2024-2029 ($ Millions)
Figure 55. United States Lacosamide Market Size 2024-2029 ($ Millions)
Figure 56. Canada Lacosamide Market Size 2024-2029 ($ Millions)
Figure 57. Mexico Lacosamide Market Size 2024-2029 ($ Millions)
Figure 58. Brazil Lacosamide Market Size 2024-2029 ($ Millions)
Figure 59. China Lacosamide Market Size 2024-2029 ($ Millions)
Figure 60. Japan Lacosamide Market Size 2024-2029 ($ Millions)
Figure 61. Korea Lacosamide Market Size 2024-2029 ($ Millions)
Figure 62. Southeast Asia Lacosamide Market Size 2024-2029 ($ Millions)
Figure 63. India Lacosamide Market Size 2024-2029 ($ Millions)
Figure 64. Australia Lacosamide Market Size 2024-2029 ($ Millions)
Figure 65. Germany Lacosamide Market Size 2024-2029 ($ Millions)
Figure 66. France Lacosamide Market Size 2024-2029 ($ Millions)
Figure 67. UK Lacosamide Market Size 2024-2029 ($ Millions)
Figure 68. Italy Lacosamide Market Size 2024-2029 ($ Millions)
Figure 69. Russia Lacosamide Market Size 2024-2029 ($ Millions)
Figure 70. Spain Lacosamide Market Size 2024-2029 ($ Millions)
Figure 71. Egypt Lacosamide Market Size 2024-2029 ($ Millions)
Figure 72. South Africa Lacosamide Market Size 2024-2029 ($ Millions)
Figure 73. Israel Lacosamide Market Size 2024-2029 ($ Millions)
Figure 74. Turkey Lacosamide Market Size 2024-2029 ($ Millions)
Figure 75. GCC Countries Lacosamide Market Size 2024-2029 ($ Millions)
Figure 76. Global Lacosamide Market Size Market Share Forecast by Type (2024-2029)
Figure 77. Global Lacosamide Market Size Market Share Forecast by Application (2024-2029)
Figure 1. Lacosamide Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Lacosamide Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Lacosamide Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Lacosamide Sales Market Share by Country/Region (2022)
Figure 8. Lacosamide Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Lacosamide Market Size Market Share by Type in 2022
Figure 10. Lacosamide in Adults
Figure 11. Global Lacosamide Market: Adults (2018-2023) & ($ Millions)
Figure 12. Lacosamide in Pediatric patients
Figure 13. Global Lacosamide Market: Pediatric patients (2018-2023) & ($ Millions)
Figure 14. Global Lacosamide Market Size Market Share by Application in 2022
Figure 15. Global Lacosamide Revenue Market Share by Player in 2022
Figure 16. Global Lacosamide Market Size Market Share by Regions (2018-2023)
Figure 17. Americas Lacosamide Market Size 2018-2023 ($ Millions)
Figure 18. APAC Lacosamide Market Size 2018-2023 ($ Millions)
Figure 19. Europe Lacosamide Market Size 2018-2023 ($ Millions)
Figure 20. Middle East & Africa Lacosamide Market Size 2018-2023 ($ Millions)
Figure 21. Americas Lacosamide Value Market Share by Country in 2022
Figure 22. United States Lacosamide Market Size Growth 2018-2023 ($ Millions)
Figure 23. Canada Lacosamide Market Size Growth 2018-2023 ($ Millions)
Figure 24. Mexico Lacosamide Market Size Growth 2018-2023 ($ Millions)
Figure 25. Brazil Lacosamide Market Size Growth 2018-2023 ($ Millions)
Figure 26. APAC Lacosamide Market Size Market Share by Region in 2022
Figure 27. APAC Lacosamide Market Size Market Share by Type in 2022
Figure 28. APAC Lacosamide Market Size Market Share by Application in 2022
Figure 29. China Lacosamide Market Size Growth 2018-2023 ($ Millions)
Figure 30. Japan Lacosamide Market Size Growth 2018-2023 ($ Millions)
Figure 31. Korea Lacosamide Market Size Growth 2018-2023 ($ Millions)
Figure 32. Southeast Asia Lacosamide Market Size Growth 2018-2023 ($ Millions)
Figure 33. India Lacosamide Market Size Growth 2018-2023 ($ Millions)
Figure 34. Australia Lacosamide Market Size Growth 2018-2023 ($ Millions)
Figure 35. Europe Lacosamide Market Size Market Share by Country in 2022
Figure 36. Europe Lacosamide Market Size Market Share by Type (2018-2023)
Figure 37. Europe Lacosamide Market Size Market Share by Application (2018-2023)
Figure 38. Germany Lacosamide Market Size Growth 2018-2023 ($ Millions)
Figure 39. France Lacosamide Market Size Growth 2018-2023 ($ Millions)
Figure 40. UK Lacosamide Market Size Growth 2018-2023 ($ Millions)
Figure 41. Italy Lacosamide Market Size Growth 2018-2023 ($ Millions)
Figure 42. Russia Lacosamide Market Size Growth 2018-2023 ($ Millions)
Figure 43. Middle East & Africa Lacosamide Market Size Market Share by Region (2018-2023)
Figure 44. Middle East & Africa Lacosamide Market Size Market Share by Type (2018-2023)
Figure 45. Middle East & Africa Lacosamide Market Size Market Share by Application (2018-2023)
Figure 46. Egypt Lacosamide Market Size Growth 2018-2023 ($ Millions)
Figure 47. South Africa Lacosamide Market Size Growth 2018-2023 ($ Millions)
Figure 48. Israel Lacosamide Market Size Growth 2018-2023 ($ Millions)
Figure 49. Turkey Lacosamide Market Size Growth 2018-2023 ($ Millions)
Figure 50. GCC Country Lacosamide Market Size Growth 2018-2023 ($ Millions)
Figure 51. Americas Lacosamide Market Size 2024-2029 ($ Millions)
Figure 52. APAC Lacosamide Market Size 2024-2029 ($ Millions)
Figure 53. Europe Lacosamide Market Size 2024-2029 ($ Millions)
Figure 54. Middle East & Africa Lacosamide Market Size 2024-2029 ($ Millions)
Figure 55. United States Lacosamide Market Size 2024-2029 ($ Millions)
Figure 56. Canada Lacosamide Market Size 2024-2029 ($ Millions)
Figure 57. Mexico Lacosamide Market Size 2024-2029 ($ Millions)
Figure 58. Brazil Lacosamide Market Size 2024-2029 ($ Millions)
Figure 59. China Lacosamide Market Size 2024-2029 ($ Millions)
Figure 60. Japan Lacosamide Market Size 2024-2029 ($ Millions)
Figure 61. Korea Lacosamide Market Size 2024-2029 ($ Millions)
Figure 62. Southeast Asia Lacosamide Market Size 2024-2029 ($ Millions)
Figure 63. India Lacosamide Market Size 2024-2029 ($ Millions)
Figure 64. Australia Lacosamide Market Size 2024-2029 ($ Millions)
Figure 65. Germany Lacosamide Market Size 2024-2029 ($ Millions)
Figure 66. France Lacosamide Market Size 2024-2029 ($ Millions)
Figure 67. UK Lacosamide Market Size 2024-2029 ($ Millions)
Figure 68. Italy Lacosamide Market Size 2024-2029 ($ Millions)
Figure 69. Russia Lacosamide Market Size 2024-2029 ($ Millions)
Figure 70. Spain Lacosamide Market Size 2024-2029 ($ Millions)
Figure 71. Egypt Lacosamide Market Size 2024-2029 ($ Millions)
Figure 72. South Africa Lacosamide Market Size 2024-2029 ($ Millions)
Figure 73. Israel Lacosamide Market Size 2024-2029 ($ Millions)
Figure 74. Turkey Lacosamide Market Size 2024-2029 ($ Millions)
Figure 75. GCC Countries Lacosamide Market Size 2024-2029 ($ Millions)
Figure 76. Global Lacosamide Market Size Market Share Forecast by Type (2024-2029)
Figure 77. Global Lacosamide Market Size Market Share Forecast by Application (2024-2029)
